As of 2025-06-20, the EV/EBITDA ratio of Selecta Biosciences Inc (SELB) is -1.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SELB's latest enterprise value is 47.20 mil USD. SELB's TTM EBITDA according to its financial statements is -36.19 mil USD. Dividing these 2 quantities gives us the above SELB EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 12.0x | 10.0x |
| Forward P/E multiples | 11.1x - 20.2x | 15.6x |
| Fair Price | (1.31) - 1.47 | (0.26) |
| Upside | -249.0% - 67.1% | -129.2% |
| Date | EV/EBITDA |